Grafa News and Videos — Page 42

RedCloud (NASDAQ:RCT) reported revenue of $24 million for the six months ended June 30, 2026, an increase of 34% year over year, as total trading volume increased to $1.56 billion.

Ten-League International Holdings (NASDAQ:TLIH) reported unaudited first-half 2026 revenue of S$33.1 million for the six months ended June 30, 2026, with revenue declining as equipment and parts sales decreased.

Rich Sparkle Holdings (NASDAQ:ANPA) reported unaudited revenue of US$2.12 million for the six months ended March 31, 2026, representing a 21.8% increase compared with the prior-year period.

Sarepta Therapeutics (NASDAQ:SRPT) presented new clinical data showing ELEVIDYS (delandistrogene moxeparvovec) was associated with functional benefits in older ambulatory patients with Duchenne muscular dystrophy at the World Muscle Society Congress 2026.

Recon Technology (NASDAQ:RCON) reported fiscal 2026 revenue of RMB109.9 million for the year ended June 30, 2026, an increase of 65.8% from the prior fiscal year.

OSI Systems (NASDAQ:OSIS) announced that its Security division received orders totaling approximately $23 million from a North America customer to provide civil works, service and support for cargo inspection systems.

Novo Nordisk (NYSE:NVO) presented new CagriSema clinical data at EASD 2026, including studies evaluating food-related brain responses, organ fat changes and weight reduction in adults with overweight or obesity.

Merck (NYSE:MRK) reported Phase 2b MK-7240-012 trial results showing investigational tulisokibart achieved the primary endpoint of Hidradenitis Suppurativa Clinical Response 50 (HiSCR50) at Week 16 in patients with moderate to severe hidradenitis suppurativa.

HomesToLife (NASDAQ:HTLM) reported unaudited first-half 2026 net revenue of US$198.3 million, up 10% year over year as export sales increased and retail sales expanded.

Eli Lilly (NYSE:LLY) reported Phase 3b ADtouch study results showing EBGLYSS monotherapy met its primary and secondary endpoints in adults and adolescents with hand-and-foot atopic dermatitis.